Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets Details (Tables)

v3.21.1
Balance Sheets Details (Tables)
3 Months Ended
Mar. 31, 2021
Balance Sheets Details [Abstract]  
Schedule of cash and cash equivalents
Cash equivalents as of March 31, 2021 and December 31, 2020, consisted of the following (in thousands):

  March 31, 2021 December 31, 2020
  Adjusted Cost Estimated Fair Value Adjusted Cost Estimated Fair Value
Money market funds (1)
$ 122,075  $ 122,075  $ 127,567  $ 127,567 
(1) Money market funds are classified in cash and cash equivalents on our consolidated balance sheets. Average Contractual Maturities (in days) is not applicable.
Schedule of inventory components
Inventories consisted of the following (in thousands):
March 31, 2021 December 31, 2020
Raw materials $ 77  $ 77 
Work-in-process 107  82 
Finished goods 845  805 
    Inventories $ 1,029  $ 964 
Schedule of property and equipment, net
Property and equipment, net consisted of the following (in thousands):
March 31, 2021 December 31, 2020
Laboratory equipment $ 27,491  $ 25,468 
Leasehold improvements 10,785  10,785 
Computer equipment and software 3,236  3,192 
Office equipment and furniture 1,246  1,246 
Construction in progress 1,375  2,357 
Property and equipment 44,133  43,048 
       Less: accumulated depreciation and amortization (33,737) (33,373)
     Property and equipment, net $ 10,396  $ 9,675 

Depreciation expense included in the Unaudited Condensed Consolidated Statements of Operations was follows (in thousands):
Three months ended March 31,
2021 2020
Depreciation Expense $ 659  $ 438 
Schedule of other accrued liabilities
Other accrued liabilities consisted of the following (in thousands):
March 31, 2021 December 31, 2020
Accrued purchases $ 5,749  $ 7,170 
Accrued professional and outside service fees 3,527  2,589 
Other 240  513 
     Total $ 9,516  $ 10,272